for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery.long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome).

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. it is also used for treatment of high blood pressure. it may also be used to treat or prevent low blood potassium.

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures.short-term preoperative treatment of patients with primary hyperaldosteronism

this product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions..

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial.

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. it is also used for treatment of high blood pressure.short-term preoperative treatment of patients with primary hyperaldosteronism.long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). it may also be used to treat or prevent low blood potassium. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. all products are authentic brand names and will include a product information insert in english.

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery.

medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome)

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery.

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures.medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome). aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.short-term preoperative treatment of patients with primary hyperaldosteronism..

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response

for the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. aldactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate.

aldactone (spironolactone) is indicated in the management of: establishing the diagnosis of primary hyperaldosteronism by therapeutic trial..long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).medical information:

aldactone is used for: treating swelling and fluid retention inpatients with congestive heart failure, cirrhosis, or kidney problems (nephrotic syndrome). it may also be used to treat or prevent low blood potassium.

for nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.

long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. it is also used for treatment of high blood pressure.short-term preoperative treatment of patients with primary hyperaldosteronism